Acadia Pharmaceuticals (ACAD) Finished Goods (2016 - 2026)
Acadia Pharmaceuticals' Finished Goods was $34.36 million in Q2 2026, up 46.6% from $23.44 million a year earlier and up 3.6% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Finished Goods (2016 - 2026) Analysis & Trends
At the end of FY2025, Finished Goods at Acadia Pharmaceuticals came in at $25.95 million, up 26.8% from FY2024.
- Finished Goods has now increased for four consecutive years, with a five-year compound annual growth rate of 78.0% (FY2020 to FY2025).
- In earlier years, Finished Goods was $20.46 million in FY2024 (+309.1%), $5 million in FY2023 (+159.7%), $1.93 million in FY2022 (+72.9%) and $1.11 million in FY2021 (-23.3%).
- The Q2 2026 figure marks the highest quarterly Finished Goods in data going back to Q2 2016.
- Compared with a year earlier, Finished Goods has increased for 12 straight quarters, with growth averaging 124.0% over the last eight quarters.
- The best year-over-year quarter for Finished Goods over five years was Q2 2024 (growth of 758.5%); the worst was Q4 2021 (a decline of 23.3%).
- Per Business Quant data, ACAD's Finished Goods in the three quarters before Q2 2026 was $33.17 million (Q1 2026), $25.95 million (Q4 2025) and $25.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.99 Bn | 1,104.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.90 Bn | 535.42 Bn | 17.26 Bn |
| 3 | AbbVie | 501.56 Bn | 474.68 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.13 Bn | 12.86 Bn |
| 7 | Amgen | 236.48 Bn | 191.88 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.56 Bn | 164.76 Bn | 6.22 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn |
| 10 | Acadia Pharmaceuticals | 3.46 Bn | -15.12 Mn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.36 Mn |
| Mar 31, 2026 | 33.17 Mn |
| Dec 31, 2025 | 25.95 Mn |
| Sep 30, 2025 | 25.03 Mn |
| Jun 30, 2025 | 23.44 Mn |
| Mar 31, 2025 | 23.86 Mn |
| Dec 31, 2024 | 20.46 Mn |
| Sep 30, 2024 | 19.13 Mn |
| Jun 30, 2024 | 17.21 Mn |
| Mar 31, 2024 | 7.58 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 4.93 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.59 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 1.73 Mn |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 1.45 Mn |
API Access
Acadia Pharmaceuticals Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();